(S)-3-hydroxy-3-(pyridin-4-yl)propanenitrile | 676563-19-2

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: (S)-3-hydroxy-3-(pyridin-4-yl)propanenitrile
• 英文别名: (3S)-3-hydroxy-3-pyridin-4-ylpropanenitrile
• CAS: 676563-19-2
• 化学式: C₈H₈N₂O
• 分子量: 148.164
• InChiKey: BURCZJNCKSLVSZ-QMMMGPOBSA-N

物化性质

• 沸点：
  385.3±27.0 °C(Predicted)
• 密度：
  1.198±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  56.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-氧代-3-(4-吡啶基)丙腈 在 Almag CRED A₁₃₁ 、 NADP 、 glucose dehydrogenase 作用下， 以 水 、 二甲基亚砜 、 异丙醇 为溶剂， 35.0 ℃ 、50.0 kPa 条件下， 以44%的产率得到(S)-3-hydroxy-3-(pyridin-4-yl)propanenitrile
  参考文献：
  名称：

  Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology

  摘要：

  Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme (TM) carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in >= 99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2013.09.015

文献信息

• Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives
  申请人：——

  公开号：US20040181058A1

  公开（公告）日：2004-09-16

  The invention relates to a process for preparing enantiomer-enriched 3-heteroaryl-3-hydroxypropanoic acid derivatives and 3-heteroaryl-1-aminopropan-3-ols, and to their use.

  本发明涉及一种制备对映体富集的3-杂环基-3-羟基丙酸衍生物和3-杂环基-1-氨基丙烷-3-醇的方法，以及它们的用途。
• Verfahren zur Herstellung von 3-Heteroaryl-3-hydroxy-propansäurederivaten durch enantionselektive mikrobielle Reduktion
  申请人：Bayer Chemicals AG

  公开号：EP1405917A2

  公开（公告）日：2004-04-07

  Die Erfindung betrifft ein Verfahren zur Herstellung von enantiomerenangereicherten 3-Heteroaryl-3-hydroxy-propansäurederivaten und 3-Heteroaryl-1-amino-propan-3-olen sowie deren Verwendung.

  本发明涉及一种制备对映体富集的 3-heteroaryl-3-hydroxy-propanic acid 衍生物和 3-heteroaryl-1-amino-propan-3-ols 的工艺及其用途。
• Verfahren zur Herstellung von 3-Heteroaryl-3-hydroxy-propansäurederivaten durch enantioselektive mikrobielle Reduktion
  申请人：Saltigo GmbH

  公开号：EP1405917B1

  公开（公告）日：2013-08-14
• US7553970B2
  申请人：——

  公开号：US7553970B2

  公开（公告）日：2009-06-30
• Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology
  作者：Andrew S. Rowan、Thomas S. Moody、Roger M. Howard、Toby J. Underwood、Iain R. Miskelly、Yanan He、Bo Wang

  DOI：10.1016/j.tetasy.2013.09.015

  日期：2013.11

  Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme (TM) carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in >= 99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield. (C) 2013 Elsevier Ltd. All rights reserved.